KLP Kapitalforvaltning AS Buys 3,300 Shares of Astera Labs, Inc. $ALAB

KLP Kapitalforvaltning AS boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 11.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 31,100 shares of the company’s stock after buying an additional 3,300 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Astera Labs were worth $6,089,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Astera Labs during the second quarter valued at $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the 2nd quarter worth about $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after purchasing an additional 461 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC grew its position in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after buying an additional 283 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ALAB has been the topic of several analyst reports. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Stifel Nicolaus increased their price target on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. TD Cowen reduced their price target on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research report on Wednesday, November 5th. Barclays reiterated an “equal weight” rating and issued a $155.00 price objective on shares of Astera Labs in a report on Monday, October 20th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $188.17.

Astera Labs Stock Up 3.8%

ALAB opened at $162.61 on Friday. The stock has a market cap of $27.46 billion, a P/E ratio of 146.50, a P/E/G ratio of 2.14 and a beta of 1.50. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a fifty day simple moving average of $159.79 and a 200 day simple moving average of $162.80.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the previous year, the firm earned $0.23 earnings per share. The company’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $668,467.80. Following the sale, the general counsel directly owned 147,040 shares in the company, valued at approximately $21,275,217.60. This trade represents a 3.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief operating officer directly owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 576,936 shares of company stock worth $87,409,540 in the last quarter. Company insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.